These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30015899)

  • 1. TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma.
    Li C; Cai J; Ge F; Wang G
    Int J Mol Med; 2018 Oct; 42(4):1799-1808. PubMed ID: 30015899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA circ_0081001 knockdown enhances methotrexate sensitivity in osteosarcoma cells by regulating miR-494-3p/TGM2 axis.
    Wei W; Ji L; Duan W; Zhu J
    J Orthop Surg Res; 2021 Jan; 16(1):50. PubMed ID: 33435987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Stim1 expression is associated with acquired chemo-resistance of cisplatin in osteosarcoma cells.
    Sun X; Wei Q; Cheng J; Bian Y; Tian C; Hu Y; Li H
    Hum Cell; 2017 Jul; 30(3):216-225. PubMed ID: 28326487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone methyltransferase NSD2 regulates apoptosis and chemosensitivity in osteosarcoma.
    He C; Liu C; Wang L; Sun Y; Jiang Y; Hao Y
    Cell Death Dis; 2019 Jan; 10(2):65. PubMed ID: 30683853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis.
    Wang Y; Zhang L; Zheng X; Zhong W; Tian X; Yin B; Tian K; Zhang W
    Cancer Lett; 2016 Nov; 382(2):137-146. PubMed ID: 27609068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lncRNA ANRIL knockdown on proliferation and cisplatin chemoresistance of osteosarcoma cells in vitro.
    Li G; Zhu Y
    Pathol Res Pract; 2019 May; 215(5):931-938. PubMed ID: 30777616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma.
    Xiao X; Wang W; Li Y; Yang D; Li X; Shen C; Liu Y; Ke X; Guo S; Guo Z
    J Exp Clin Cancer Res; 2018 Aug; 37(1):201. PubMed ID: 30153855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCN2 enhances resistance to cisplatin-mediating cell apoptosis in human osteosarcoma.
    Tsai HC; Huang CY; Su HL; Tang CH
    PLoS One; 2014; 9(3):e90159. PubMed ID: 24637722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA interference-mediated knockdown of Livin suppresses cell proliferation and invasion and enhances the chemosensitivity to cisplatin in human osteosarcoma cells.
    Li X; Fan S; Li L; Wang L; Fan G; Zhao Q; Li Y
    Int J Oncol; 2013 Jul; 43(1):159-68. PubMed ID: 23632777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressing CHD1L reduces the proliferation and chemoresistance in osteosarcoma.
    Fan GT; Ling ZH; He ZW; Wu SJ; Zhou GX
    Biochem Biophys Res Commun; 2021 May; 554():214-221. PubMed ID: 33813077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podocalyxin promotes cisplatin chemoresistance in osteosarcoma cells through phosphatidylinositide 3-kinase signaling.
    Huang Z; Huang Y; He H; Ni J
    Mol Med Rep; 2015 Sep; 12(3):3916-3922. PubMed ID: 26017117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing LPAATβ inhibits tumor growth of cisplatin-resistant human osteosarcoma in vivo and in vitro.
    Song L; Duan P; Gan Y; Li P; Zhao C; Xu J; Zhang Z; Zhou Q
    Int J Oncol; 2017 Feb; 50(2):535-544. PubMed ID: 28035350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-223/Hsp70/JNK/JUN/miR-223 feedback loop modulates the chemoresistance of osteosarcoma to cisplatin.
    Tang Q; Yuan Q; Li H; Wang W; Xie G; Zhu K; Li D
    Biochem Biophys Res Commun; 2018 Mar; 497(3):827-834. PubMed ID: 29432736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagy.
    Kim M; Jung JY; Choi S; Lee H; Morales LD; Koh JT; Kim SH; Choi YD; Choi C; Slaga TJ; Kim WJ; Kim DJ
    Autophagy; 2017 Jan; 13(1):149-168. PubMed ID: 27754745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer.
    Park KS; Kim HK; Lee JH; Choi YB; Park SY; Yang SH; Kim SY; Hong KM
    J Cancer Res Clin Oncol; 2010 Apr; 136(4):493-502. PubMed ID: 19763620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGM2: a cell surface marker in esophageal adenocarcinomas.
    Leicht DT; Kausar T; Wang Z; Ferrer-Torres D; Wang TD; Thomas DG; Lin J; Chang AC; Lin L; Beer DG
    J Thorac Oncol; 2014 Jun; 9(6):872-81. PubMed ID: 24828664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTBP1 modulates osteosarcoma chemoresistance to cisplatin by regulating the expression of the copper transporter SLC31A1.
    Cheng C; Ding Q; Zhang Z; Wang S; Zhong B; Huang X; Shao Z
    J Cell Mol Med; 2020 May; 24(9):5274-5289. PubMed ID: 32207235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer potential of TUG1 knockdown in cisplatin-resistant osteosarcoma through inhibition of MET/Akt signalling.
    Zhou Q; Hu T; Xu Y
    J Drug Target; 2020 Feb; 28(2):204-211. PubMed ID: 31305159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secreted clusterin (sCLU) regulates cell proliferation and chemosensitivity to cisplatin by modulating ERK1/2 signals in human osteosarcoma cells.
    Huang H; Wang L; Li M; Wang X; Zhang L
    World J Surg Oncol; 2014 Aug; 12():255. PubMed ID: 25106434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-34a increases cisplatin sensitivity of osteosarcoma cells in vitro through up-regulation of c-Myc and Bim signal.
    Li QC; Xu H; Wang X; Wang T; Wu J
    Cancer Biomark; 2017 Dec; 21(1):135-144. PubMed ID: 29060932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.